Oral bisphosphonates, among them Fosamax, have been widely prescribed over the years to prevent or delay the negative consequences of bone problems such as osteoporosis and Paget’s disease, which causes the bones to become fragile and more susceptible to fractures, medical experts say. The blog on Fosamax drug injury cases contains important information about the side-effects associated with the drug. However, first time users of Fosamax are at increased risk of getting scleritis and anterior uveitis, warned medical experts. Scleritis is the inflammation of the sclera, the white part of the eye, which when left untreated, may cause glaucoma, cataracts, retinal damage or detachment, optic nerve damage and shrinkage of the eyes. Uveitis is the inflammation inside of the eye, and is the 5th or 6th cause of blindness in the US.

The inflammatory eye conditions are potentially reversible if identified early, however the labels on osteoporosis drugs do not mention eye inflammation. Patients and their doctors need to be familiar with the symptoms so they can seek immediate and early intervention from an ophthalmologist.

References:

health.usnews.com/health-news/news/articles/2012/04/02/osteoporosis-drugs-may-lead-to-eye-trouble-study

adverseevents.com/monitor/2012/04/04/study-links-bisphosphonates-to-serious-inflammatory-eye-diseases/

summitmedicalgroup.com/healthday/article/619683/